moxonidine has been researched along with Innate Inflammatory Response in 4 studies
moxonidine: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| " We compared the effect of two sympatholytic antihypertensive drug treatments, the centrally acting imidazoline receptor-1 agonist moxonidine and peripherally acting beta-blocking agent atenolol on sensitive inflammatory markers in overweight postmenopausal women with diastolic hypertension." | 5.13 | Central sympatholytic therapy has anti-inflammatory properties in hypertensive postmenopausal women. ( Antikainen, RL; Ebeling, PE; Erkkola, RU; Kaaja, RJ; Katzman, P; Kibarskis, A; Manhem, K; Pöyhönen-Alho, MK; Tuomilehto, JO, 2008) |
| "Regression of left ventricular hypertrophy by moxonidine, a centrally acting sympatholytic imidazoline compound, results from a sustained reduction of DNA synthesis and transient stimulation of DNA fragmentation." | 3.77 | Moxonidine improves cardiac structure and performance in SHR through inhibition of cytokines, p38 MAPK and Akt. ( Aceros, H; Cobos-Puc, L; Farah, G; Mukaddam-Daher, S; Noiseux, N; Stabile, AM, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saunders, MJ | 1 |
| Edwards, BS | 1 |
| Zhu, J | 1 |
| Sklar, LA | 1 |
| Graves, SW | 1 |
| Hausberg, M | 1 |
| Hillebrand, U | 1 |
| Kisters, K | 1 |
| Pöyhönen-Alho, MK | 1 |
| Manhem, K | 1 |
| Katzman, P | 1 |
| Kibarskis, A | 1 |
| Antikainen, RL | 1 |
| Erkkola, RU | 1 |
| Tuomilehto, JO | 1 |
| Ebeling, PE | 1 |
| Kaaja, RJ | 1 |
| Aceros, H | 1 |
| Farah, G | 1 |
| Cobos-Puc, L | 1 |
| Stabile, AM | 1 |
| Noiseux, N | 1 |
| Mukaddam-Daher, S | 1 |
1 trial available for moxonidine and Innate Inflammatory Response
| Article | Year |
|---|---|
Central sympatholytic therapy has anti-inflammatory properties in hypertensive postmenopausal women.
Topics: Adiponectin; Antihypertensive Agents; Atenolol; C-Reactive Protein; Double-Blind Method; Female; Fin | 2008 |
3 other studies available for moxonidine and Innate Inflammatory Response
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
Addressing the relationship between sympathetic activity and inflammation.
Topics: Antihypertensive Agents; Atenolol; C-Reactive Protein; Female; Humans; Hypertension; Imidazoles; Inf | 2008 |
Moxonidine improves cardiac structure and performance in SHR through inhibition of cytokines, p38 MAPK and Akt.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cell Death; Cell Survival; Collagen; Cytokines; Ec | 2011 |